-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Downgrades KalVista Pharmaceuticals to Hold

Benzinga·04/30/2026 18:02:22
Listen to the news
Needham analyst Serge Belanger downgrades KalVista Pharmaceuticals (NASDAQ:KALV) from Buy to Hold.